OKUROnKure Therapeutics, Inc. Class A Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key: 19615
Ticker: OKUR
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2024-10-07
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: OKUR

Detail

Enriched 2026-08-14 20:47

Market cap: $159,150,494.37
Shares outstanding (class): 40,395,480
Shares outstanding (weighted): 40,496,309
SIC: 2834 PHARMACEUTICAL PREPARATIONS
Employees: 45
Location: BOULDER, CO
Homepage: https://www.onkuretherapeutics.com
Description: OnKure Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing precision medicines that target biologically validated drivers of cancers underserved by available therapies. The company uses a structure-based drug design platform to develop a pipeline of drug candidates aimed at optimizing efficacy and tolerability. The company has multiple programs focused on targeting oncogenic PI3Kα. Its flagship program is OKI-219. The company operates in one operating segment: clinical research.

Market cap and share counts drift.

Funds holding this security

6 funds · 6 positions · $2.60M reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS	VTI	$2.11M	0.00%	510,161 NS	FIGI
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS	VXF	$299.4K	0.00%	72,316 NS	FIGI
iShares Micro-Cap ETF iShares Trust	IWC	$115.2K	0.01%	27,825 NS	FIGI
Ultra-Small Company Fund Bridgeway Funds, Inc.	—	$67.5K	0.08%	16,293 NS	FIGI
1290 VT Micro Cap Portfolio EQ Advisors Trust	—	$7.3K	0.00%	1,762 NS	FIGI
Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds	—	$1.5K	0.00%	370 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKEROKUR
FIGI_COMPOSITEBBG00JVRSRC1
FIGI_SHARE_CLASSBBG00JVRSRD0
CIK0001637715
ISINUS68277Q1058
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Pharmaceuticals
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: Common stock of a pharmaceutical company, classified under healthcare and pharmaceuticals.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.